RDHL ▲ +5.1% - RedHill Biopharma Ltd.
$RDHL RDHL RDHL - Two Leading Labs Confirm RHB-204 MAP-Killing Effect for RedHill's Crohn's Disease Candidate
02-NOV-2026 07:00 AM ET
Share this post
More filings for $RDHL
RDHL ▲ +8.3% - RedHill Biopharma Ltd.Nov 17, 2026RDHL ▲ +4.2% - RedHill Biopharma Ltd.Oct 19, 2026RDHL ▼ -2.1% - RedHill Biopharma Ltd.Sep 30, 2026RDHL ▼ -2.2% - RedHill Biopharma Ltd.Sep 1, 2026RDHL ▼ -2.2% - RedHill Biopharma Ltd.Sep 1, 2026RDHL ▼ -4.3% - RedHill Biopharma Ltd.Sep 1, 2026
View full $RDHL filing history →💬 Comments
Loading comments…
Leave a comment
